Manutan International SA
LSE:0F6I
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Manutan International SA
LSE:0F6I
|
FR |
|
R
|
Roche Holding AG
XBER:RHO5
|
CH |
|
C
|
Credit Agricole SA
OTC:CRARY
|
FR |
|
Aware Inc
NASDAQ:AWRE
|
US |
|
Telia Company AB
STO:TELIA
|
SE |
|
H
|
Hengsheng Energy Co Ltd
SSE:605580
|
CN |
|
SSAB AB
STO:SSAB A
|
SE |
|
Halozyme Therapeutics Inc
NASDAQ:HALO
|
US |
|
Launch Tech Co Ltd
HKEX:2488
|
CN |
|
N
|
Ningxia Younglight Chemicals Co Ltd
SZSE:000635
|
CN |
Balance Sheet
Balance Sheet Decomposition
Manutan International SA
Manutan International SA
Balance Sheet
Manutan International SA
| Sep-2013 | Sep-2014 | Sep-2015 | Sep-2016 | Sep-2017 | Sep-2018 | Sep-2019 | Sep-2020 | Sep-2021 | Sep-2022 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
80
|
83
|
72
|
78
|
87
|
72
|
95
|
90
|
111
|
110
|
|
| Cash |
43
|
53
|
59
|
73
|
71
|
66
|
65
|
79
|
100
|
95
|
|
| Cash Equivalents |
37
|
30
|
13
|
5
|
16
|
6
|
30
|
12
|
11
|
15
|
|
| Total Receivables |
135
|
132
|
171
|
166
|
182
|
201
|
187
|
186
|
210
|
212
|
|
| Accounts Receivables |
131
|
129
|
160
|
162
|
180
|
199
|
186
|
183
|
206
|
205
|
|
| Other Receivables |
4
|
3
|
11
|
4
|
2
|
2
|
1
|
3
|
4
|
7
|
|
| Inventory |
37
|
40
|
56
|
58
|
63
|
68
|
73
|
91
|
85
|
101
|
|
| Other Current Assets |
5
|
5
|
0
|
6
|
6
|
6
|
8
|
8
|
9
|
12
|
|
| Total Current Assets |
256
|
259
|
299
|
309
|
338
|
347
|
364
|
375
|
414
|
435
|
|
| PP&E Net |
113
|
107
|
105
|
99
|
94
|
102
|
116
|
146
|
139
|
137
|
|
| PP&E Gross |
113
|
107
|
105
|
99
|
94
|
102
|
116
|
0
|
139
|
137
|
|
| Accumulated Depreciation |
65
|
74
|
87
|
90
|
96
|
97
|
106
|
0
|
124
|
132
|
|
| Intangible Assets |
26
|
33
|
39
|
38
|
35
|
32
|
31
|
32
|
32
|
35
|
|
| Goodwill |
90
|
98
|
150
|
145
|
144
|
143
|
170
|
166
|
168
|
170
|
|
| Long-Term Investments |
2
|
2
|
2
|
2
|
2
|
2
|
4
|
3
|
1
|
3
|
|
| Other Long-Term Assets |
3
|
3
|
3
|
4
|
4
|
5
|
5
|
7
|
7
|
8
|
|
| Other Assets |
90
|
98
|
150
|
145
|
144
|
143
|
170
|
166
|
168
|
170
|
|
| Total Assets |
490
N/A
|
501
+2%
|
598
+19%
|
596
0%
|
618
+4%
|
632
+2%
|
690
+9%
|
729
+6%
|
762
+5%
|
787
+3%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
63
|
64
|
85
|
84
|
91
|
92
|
103
|
98
|
116
|
124
|
|
| Accrued Liabilities |
21
|
14
|
12
|
18
|
22
|
24
|
24
|
22
|
30
|
34
|
|
| Short-Term Debt |
4
|
4
|
12
|
10
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
7
|
6
|
12
|
12
|
12
|
15
|
18
|
22
|
19
|
15
|
|
| Other Current Liabilities |
17
|
20
|
25
|
19
|
24
|
22
|
22
|
23
|
24
|
23
|
|
| Total Current Liabilities |
113
|
107
|
146
|
143
|
149
|
153
|
166
|
165
|
189
|
197
|
|
| Long-Term Debt |
42
|
36
|
72
|
62
|
50
|
33
|
48
|
65
|
35
|
24
|
|
| Deferred Income Tax |
6
|
8
|
10
|
10
|
10
|
11
|
10
|
10
|
10
|
1
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
2
|
2
|
3
|
3
|
4
|
4
|
6
|
7
|
6
|
6
|
|
| Total Liabilities |
162
N/A
|
154
-5%
|
230
+50%
|
218
-5%
|
213
-2%
|
200
-6%
|
230
+15%
|
246
+7%
|
241
-2%
|
228
-5%
|
|
| Equity | |||||||||||
| Common Stock |
15
|
15
|
15
|
15
|
15
|
15
|
15
|
15
|
15
|
15
|
|
| Retained Earnings |
308
|
327
|
347
|
359
|
385
|
411
|
440
|
462
|
501
|
539
|
|
| Additional Paid In Capital |
6
|
6
|
6
|
6
|
6
|
6
|
6
|
6
|
6
|
6
|
|
| Treasury Stock |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
328
N/A
|
347
+6%
|
367
+6%
|
379
+3%
|
405
+7%
|
431
+7%
|
460
+7%
|
482
+5%
|
521
+8%
|
559
+7%
|
|
| Total Liabilities & Equity |
490
N/A
|
501
+2%
|
598
+19%
|
596
0%
|
618
+4%
|
632
+2%
|
690
+9%
|
729
+6%
|
762
+5%
|
787
+3%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
8
|
8
|
8
|
8
|
8
|
8
|
8
|
8
|
8
|
8
|
|